No Detail Found!

Impact of Intraoperative Dexmedetomidine versus Remifentanil on Recovery Characteristics following Laparoscopic Sleeve Gastrectomy

Author(s)
Abdul Sattar Narejo Department of Anesthesia, King Saud University Medical City,Riyadh,Saudi Arabia
Muhammad Musa Khan Department of Anesthesia, King Saud University Medical City,Riyadh,Saudi Arabia
Ali Alwhabi Department of Anesthesia, King Saud University Medical City,Riyadh,Saudi Arabia
Adel Alqarni Department of Anesthesia, King Saud University Medical City,Riyadh,Saudi Arabia
Abdulaziz Ejaz Ahmed Department of Anesthesia, King Saud University Medical City,Riyadh,Saudi Arabia
Abdelazeem Ali Eldawlatly Department of Anesthesia, King Saud University Medical City,Riyadh,Saudi Arabia
Abstract
Objective: To evaluate the impact of intraoperative dexmedetomidineversus remifentanil on postoperative pain; and enhanced recovery pro le in patients scheduled for laparoscopic sleeve gastrectomy (LSG). Study Design: Clinical observational double-blind pilot study. Place and Duration of Study:King Khalid University Hospital, a liated with King Saud University, Riyadh, Saudi Arabia, from December 2019 to March 2020. Methodology: Forty adult patients with body mass index (BMI) >35 Kg/m2 were divided into two equal groups: group dexmedetomidine (D) and group remifentanil (R). In the post-anaesthesia care unit (PACU) and for 24 hours in the ward, the patients were assessed for pain score and other recovery characteristics. Results: In the PACU, the mean values of numerical rating scale (NRS) were 4.26±1.97 vs. 4.15±1.9 and morphine consumption median values were 4 vs. 1 mg in groups D and R, respectively (p >0.05). The number of patients who developed shivering were 0 vs. 6 in groups D and R, respectively (p <0.05). Sedation agitation scale (SAS) median values were 4 vs. 4 (p <0.05), postoperative nausea and vomiting (PONV) frequency was 1 vs. 6 (p >0.05) in groups D and R, respectively. The length of hospital stay (LOS) median values were 1 vs. 1 day in groups D and R, respectively (p >0.05). Conclusion: Better enhanced recovery pro le after LSG supports the use of intraoperative infusion of dexmedetomidine as an anaesthetic adjuvant versus remifentanil.
Publication Details
Page(s) 210-214
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 31, Issue: 2, Year: 2021

Request the full text from PASTIC

Keywords
Dexmedetomidine, Remifentanil, Bariatric surgery, Enhanced recovery after surgery (ERAS)
0

Citations

0

Downloads

71

Views